WaveWriter Alpha Prime 16
Device WaveWriter Alpha_NMD
PDI 08714729985068
General payments
$6,322,764
Research payments
$108,112
Through program year 2025, $6,322,764 in general payments and $108,112 in research payments were reported against WaveWriter Alpha Prime 16 (WaveWriter Alpha_NMD).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,586,911 | 34,023 |
| 2025 | Research | $15,010 | 1 |
| 2024 | General | $1,398,393 | 26,997 |
| 2024 | Research | $93,102 | 8 |
| 2023 | General | $1,136,958 | 24,197 |
| 2022 | General | $1,200,331 | 18,701 |
| 2021 | General | $171 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 153 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
103,921 general · 9 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.